someth

The convalescent sera option for containing COVID-19

Descarga: The convalescent sera option for containing COVID-19 Archivo: covid-19/JClin Invest-The convalescent sera option for containing COVID-19 Casadevall A.pdf As of early 2020, humanity is confronting a pandemic in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes coronavirus disease, abbreviated as COVID-19. At the time of this writing, SARS-CoV-2 is spreading in multiple countries,…

Leer más

Managing COVID-19 in Low- and Middle-Income Countries

Descarga: Managing COVID-19 in Low- and Middle-Income Countries Archivo: covid-19/JAMA Managing COVID -19 in low -and middle -income countries- J Hopman.pdf Thepublic health response to coronavirus disease 2019 (COVID-19) in China has illustrated that it is possible to contain COVID-19 if governments focus on tried and tested public health outbreak responses.1,2 Isolation, quarantine, social distancing,…

Leer más

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism

Descargar PDF — Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Ye… Background The ideal duration of anticoagulant therapy in elderly patients with unprovoked venous thromboembolism (VTE) has not been consistently evaluated.Methods We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) registry to compare the rate and severity of pulmonary embolism (PE) recurrences…

Leer más

Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery

Descarga: Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery Archivo: tromboembolia-venosa/infancia/Thr Res 2018 increasing rates of thrombosis in children with.pdf Objective: To determine thrombosis incidence, morbidities, and mortality of children with congenital heart disease who develop thrombosis after cardiac surgery. Materials and methods: This retrospective study reviewed patients< 18 years…

Leer más

WARFARIN & OTHER ORAL ANTICOAGULANTS GUIDELINES AND PROCEDURES

Descarga: WARFARIN & OTHER ORAL ANTICOAGULANTS GUIDELINES AND PROCEDURES Archivo: guias/reversion/GUIAS WARFARINA WORCESTERSHIRE UK.pdf  Introduction Anticoagulants are one of the classes of medicines most frequently identified as causing preventable harm and admission to hospital. Managing the risks associated with anticoagulants can reduce the chance of patients being harmed. This Trust Guideline is based on British…

Leer más

Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria

Descarga: Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria Archivo: tromboembolia-venosa/Thr Res 2018 Maufus TVP diagnostico.pdf Introduction: Recurrent deep vein thrombosis (DVT) is often suspected in patients after anticoagulant drug withdrawal. The clinical signs can be confused with the onset of post-thrombotic syndrome. For these reasons, diagnosis of DVT recurrence must rely on an accurate…

Leer más

An update on factor XI structure and function

Descarga: An update on factor XI structure and function Archivo: tromboembolia-venosa/tvp/Thr Res 2018 Mohamed-FXI.pdf Factor XI (FXI) is the zymogen of a plasma protease, factor XIa (FXIa), that contributes to thrombin generation during blood coagulation by proteolytic activation of several coagulation factors, most notably factor IX (FIX). FXI is a homolog of prekallikrein (PK), a…

Leer más

IgA anti-β2 glycoprotein I antibodies: Experience from a large center

Descarga: IgA anti-β2 glycoprotein I antibodies: Experience from a large center Archivo: tromboembolia-venosa/Thr Res IgA and b2-glycoprotein Ab.pdf Objective: IgG and IgM antibodies directed at β2-glycoprotein I are included in the classification criteria for the antiphospholipid syndrome (APS) while the IgA antibodies against β2-glycoprotein I (IgA aβ2GPI) are not.Conflicting data about the significance of IgA…

Leer más

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

Descargar PDF — Perioperative Management of Patients With Atrial Fibrillation Receiving a Dir… IMPORTANCE Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and request elective surgery or procedure present a common clinical situation yet perioperative management is uncertain. OBJECTIVE To investigate the safety of a standardized perioperative DOAC managementstrategy. DESIGN, SETTING,…

Leer más

Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)

Descarga: Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs) Archivo: tromboembolia-venosa/Thr Res 2018 Grasso-FSAP y neutrofilos.pdf The circulating zymogen form of Factor VII activating protease (FSAP) can be activated by histones and nucleosomes in vivo. These cell-death-associated nuclear factors are also actively extruded into the extracellular space by neutrophils through a…

Leer más